Richard L. Crownover, MD, PhD
Professor and Residency Program Director Department of Radiation Oncology Mays Cancer Center San Antonio, TX
Dr. Crownover obtained both his PhD in Physics and MD at Duke University in Durham North Carolina. He trained in Radiation Oncology at the University of California San Francisco. He joined the Cleveland Clinic in 1995 where he served as the Chief of the Breast and Musculoskeletal tumor services in Radiation Oncology, and also as the Director of the CyberKnife program when the CyberKnife was still under investigational device exemption. During a decade at the Cleveland Clinic he was a key player in the creation and successful growth of the multidisciplinary breast center. He was a member of the Cleveland Clinic’s Breast Cancer Quality Improvement Team. In 2005 he became the inaugural Director of the Reading Hospital and Medical Center’s newly opened Regional Cancer Center in Reading Pennsylvania. Dr. Crownover joined the Cancer Therapy and Research Center (CTRC) in 2007 where his clinical emphasis has been on treatment of breast cancer and development of a stereotactic body radiotherapy program. The CTRC subsequently became part of the University of Texas Health Science Center San Antonio and is now known as the Mays Cancer Center at UT Health San Antonio. He is a Professor of Radiation Oncology and Director of the Radiation Oncology Residency Program. Dr. Crownover is Co-Leader of Breast Multi-Disciplinary Care Team. He is an active participant in local and multi-institutional breast clinical trials. He has been a member of the RTOG Breast Committee. Other areas of research have included early applications of high-dose-rate brachytherapy for sarcomas and stereotactic body radiotherapy for lung, liver, and spinal tumors. Dr. Crownover has been named one of The Best Doctors for Women; by Ladies Home Journal and one of America’s Top Doctors; by Redbook. In 2017 he received the President’s Clinical Excellence Award; at the University of Texas Health Science Center San Antonio.